Clinical Trials in Nashville

Showing 18601-18620 of 20,298 trials

Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery

NCT00633750

RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving erlotinib before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. PURPOSE: This phase II trial is studying how well erlotinib works in treating patients with breast cancer that can be removed by surgery.

Breast Cancer

Vanderbilt-Ingram Cancer Center50 participantsStarted Aug 2002

Birmingham, Alabama, United States • Boston, Massachusetts, United States • Chapel Hill, North Carolina, United States +2 more locations

COMPLETEDPhase 2< 1 mile

Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder

NCT00196404

This is a placebo-controlled, double-blind study to evaluate the safety and efficacy of two doses of DR-3001 in women with overactive bladder who have symptoms of predominant or pure urge incontinence, urinary urgency and elevated urinary frequency

Urinary Incontinence

Duramed Research800 participantsStarted Oct 2004

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +45 more locations

Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery

Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder

Find Trials by Condition in Nashville

Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subjects With OA Pain

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain

Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study

Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma

An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma

CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse

A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors

Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux

Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment